Prednisone
Showing 26 - 50 of 2,983
Gout, Chronic Kidney Disease, Renal Transplantation Trial in Paris (Anakinra 100Mg/0.67Ml Inj Syringe, Prednisone, Placebo of
Recruiting
- Gout
- +2 more
- Anakinra 100Mg/0.67Ml Inj Syringe
- +3 more
-
Paris, Ile-De-France, FranceRhumathology department
Aug 22, 2022
Granulomatosis With Polyangiitis, Wegener Granulomatosis, Vasculitis Trial in Tampa (5 mg prednisone, 0 mg prednisone)
Active, not recruiting
- Granulomatosis With Polyangiitis
- +2 more
- 5 mg prednisone
- 0 mg prednisone
-
Tampa, FloridaUniversity of South Florida TAPIR Study Team
May 2, 2022
Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Advanced Cancer
- Cemiplimab
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone
Active, not recruiting
- Metastatic Prostate Carcinoma
- +5 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 26, 2022
Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)
Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)
Recruiting
- Prostate Cancer Metastatic
- Prostate Cancer
- Abiraterone Acetate
- Prednisone
-
Houston, Texas
- +2 more
Oct 7, 2022
Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)
Recruiting
- Lymphoma
- +3 more
- Venetoclax
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Multiple Myeloma Trial in Torino (Melphalan, Prednisone, Lenalidomide, Cyclophosphamide, Prednisone, Lenalidomide, Lenalidomide,
Active, not recruiting
- Multiple Myeloma
- Melphalan, Prednisone, Lenalidomide
- +2 more
-
Torino, TO, ItalyDivision Of Hematology, A.O.U. Città della Salute e della Scienz
Mar 24, 2022
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Dasatinib
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 16, 2022
Retroperitoneal Fibrosis Trial in Beijing (Sirolimus, Corticosteroid)
Recruiting
- Retroperitoneal Fibrosis
-
Beijing, Beijing, ChinaPeking University International Hospital
Dec 7, 2022
Chondrocalcinosis Trial in France (Colchicine opocalcium 1mg, Prednisone : Cortancyl 20mg)
Completed
- Chondrocalcinosis
- Colchicine opocalcium 1mg
- Prednisone : Cortancyl 20mg
-
Valenciennes, Hauts-de-France, France
- +6 more
Nov 28, 2022
Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)
Recruiting
- Lymphoma
- +3 more
- obinutuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate
Suspended
- Castration-Resistant Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022
Rheumatoid Arthritis Trial in Ann Arbor (Oral prednisone Taper)
Recruiting
- Rheumatoid Arthritis
- Oral prednisone Taper
-
Ann Arbor, MichiganVA Ann Arbor Healthcare System, Ann Arbor, MI
Oct 2, 2023
Multiple Myeloma Trial in Torino (Pomalidomide, Cyclophosphamide, Prednisone)
Active, not recruiting
- Multiple Myeloma
- Pomalidomide, Cyclophosphamide, Prednisone
-
Torino, ItalyAOU Città della Salute e della Scienza di Torino - SC Ematologia
Mar 24, 2022
Peripheral T Cell Lymphoma Trial in Harlingen (Belinostat Injection, Pralatrexate Injection, CHOP)
Not yet recruiting
- Peripheral T Cell Lymphoma
- Belinostat Injection
- +3 more
-
Harlingen, TexasValley Cancer Associates
Oct 16, 2023
Autoimmune Diseases Trial in Beijing (Diprospan plus iguratimod, Diprospan plus leflunomide, Prednisone plus leflunomide)
Recruiting
- Autoimmune Diseases
- Diprospan plus iguratimod
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Mar 16, 2023
DLBCL Trial in Qingdao (Selinexor combined with Prednisone, Etoposide, and Lenalidomide)
Not yet recruiting
- DLBCL
- Selinexor combined with Prednisone, Etoposide, and Lenalidomide
-
Qingdao, Shandong, Chinathe affiliated hospital of Qingdao University
Aug 18, 2022
Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, MP and CTX)
Terminated
- Idiopathic Membranous Nephropathy
- Prednisone
- MP and CTX
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Feb 2, 2022
Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial
Suspended
- Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
- Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
- Obinutuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Metastatic Castration-resistant Prostate Cancer Trial in China (TQB3823 tablets, Abiraterone acetate tablets, prednisone acetate
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- TQB3823 tablets
- +2 more
-
Chongqing, Chongqing, China
- +4 more
Jun 1, 2022
Granulomatosis With Polyangiitis Trial in Canada, United States (5 mg Prednisone, 0 mg Prednisone)
Recruiting
- Granulomatosis With Polyangiitis
- 5 mg Prednisone
- 0 mg Prednisone
-
Kansas City, Kansas
- +8 more
Jan 25, 2022
Alcoholic Hepatitis Trial in United States (Anakinra and Zinc, Prednisone, Placebos)
Completed
- Alcoholic Hepatitis
- Anakinra and Zinc
- +2 more
-
Phoenix, Arizona
- +10 more
Sep 13, 2022